Vifor Pharma Group

Overview

Vifor Pharma Group is a global pharmaceutical company specializing in the development, manufacturing, and marketing of pharmaceutical products for iron deficiency, nephrology, and cardio-renal therapies. It became a private company after being acquired by CSL Limited in 2022.

Therapeutic areas

Iron DeficiencyNephrologyCardio-Renal

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Vifor Pharma Group in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Vifor Pharma Group?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.